Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine

ConditionsSchizophrenia Clozapine Exercise

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorDr. Lutfi Kirdar Kartal Training and Research Hospital

About this trial

This prospective study aims to investigate the effects of exercise on clinical symptoms, cognitive performance, and quality of life in schizophrenia patients treated with Clozapine.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients treated who were diagnosed with schizophrenia according to DSM-V criteria by psychiatrist at the Turkish Ministry of Health Kartal Dr. Lütfi Kırdar City Hospital

using a therapeutic dose of 300-500 mg/day of clozapine,

Disqualifiers

pregnancy

Trial design

Design model

Parallel

Treatments tested in this trial

physical exercise
Other intervention
physical exercise

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: physical exercise groupExperimental treatment 1 intervention

Group B: control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

Montreal Cognitive Assessment (MOCA)

OCA is a short cognitive assessment method developed to detect particularly mild stages of cognitive impairment.

Time frame

12 weeks

Positive and Negative Syndrome Scale (PANSS)

To evaluate clinical symptoms, both the exercise and control groups will be assessed by using the Positive and Negative Syndrome Scale (PANSS)

Time frame

12 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Lead sponsor

Source ClinicalTrials.gov

Apply now